Navigation Links
NARSAD - World's Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
Date:10/5/2007

In sessions free and open to public, top scientists will focus on childhood

disorders and new directions in mental health research

NEW YORK, Oct. 5 /PRNewswire/ -- Revolutionary new methods of understanding the human brain, involving sophisticated imaging and genetic technologies, are giving rise to important new discoveries that promise better treatments for serious psychiatric illnesses. Some of the most important new insights will be shared by scientists working at the leading edge of psychiatric research who will share their findings in a free, public symposium presented by NARSAD, the world's leading charity dedicated to mental health research.

NARSAD's 19th annual New York Mental Health Symposium will take place on Friday and Saturday, October 19th and 20th, at The Times Center at 242 West 41st Street, between 7th and 8th Avenues in Manhattan. Those interested in attending are advised to reserve a place in advance by contacting NARSAD at 800-829-8289 or events@narsad.org.

The symposium's first day -- Friday the 19th, from 9 a.m. to 3 p.m. -- is devoted to a subject of great concern to the public, childhood mental health. Entitled "Healing Children's Minds," the program features presentations by five NARSAD researchers, each one a leader in his or her field. The presentations (detailed below) will be moderated by Robert M. A. Hirschfeld, M.D., of the University of Texas Medical Branch at Galveston.

The symposium session on Saturday the 20th, from 10 a.m. to 1 p.m., will highlight "New Directions in Research," with presentations on depression, schizophrenia and bipolar disorder. The Saturday session, to be moderated by Herbert Pardes, M.D., president and CEO of New York-Presbyterian Hospital and president of NARSAD's Scientific Council, will also feature commentary on each presentation by Jack Barchas, M.D., chairman of the Department of Psychiatry, Weill Cornell Medical College and psychiatrist-in-chief, NewYork-Presbyterian Hospital/Weill Cornell Medical Center and the Payne Whitney Psychiatric Clinic. (For more details on the symposium sessions, go to http://www.narsad.org/news/press/recentnews.html.)

NARSAD, since its inception in 1987, has awarded over 3,200 research grants totaling more than $219 million to scientists working in the United States and 26 other countries. Their research has focused on depression, bipolar disorder, schizophrenia, anxiety disorders and childhood mental disorders.

With free symposia in New York and other cities around the country, including Los Angeles, Boston, Washington, D.C., St. Louis, Sarasota and Palm Beach, NARSAD is creating important opportunities for the public to learn about the mechanisms behind mental illnesses and about researchers' cutting- edge thinking on causes, treatments and preventions.

On Friday, October 19th, following the first day of the New York Mental Health Research Symposium, NARSAD will hold its annual New York fundraising gala at the Waldorf Astoria. This year's gala celebrates NARSAD's 20 years of supporting groundbreaking research, and, like the Friday symposium program, is thematically dedicated to "Healing Children's Minds." NARSAD will give its first Children's Mental Health Award to KaBOOM!, an organization whose mission is to make a safe, clean playground available to every child in America. NARSAD will also award its top prizes for achievement in psychiatric research at the gala to five of the foremost investigators in the world today. For more information on NARSAD's gala and the recipients of this year's research prizes, please visit http://www.narsad.org or call NARSAD at 800-829-8289.


'/>"/>
SOURCE NARSAD
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Benefits Of The Worlds Most Widely Used Beverage
2. Worlds Largest Cord Blood Bank to be started in India
3. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
4. Worlds first mobile light surgery
5. Spanish Doctors Performs Worlds First Hand Transplantation Successfully
6. Worlds Heaviest Man Loses Weight Thanks to Monitored Dieting
7. Abu Dhabi to Have Worlds First Zero-carbon City
8. Eddie Murphy Voted Worlds Biggest Love-Rat
9. Is Diabetes the Leading Cause of Kidney Failure in India
10. Misleading anti-malarial drug
11. Misleading Advertisements for Prescription Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: